ERBB2 and neoplasm: Therefore, the results of this study suggest that in future clinical studies, it is necessary to pay more attention to the high expression of HER2 in tumor patients, in order to grasp the specific information of their disease changes and provide reliable information for the adjustment of clinical treatment plans and the reduction of the incidence of mid- to late-stage events in a timely manner.